Exercise and Glaucoma: Positive Steps Toward Finding Another Modifiable Risk Factor to Prevent Vision Loss.

Can Home Monitoring Allow Earlier Detection of Rapid Visual Field Progression in Glaucoma?

Comparison of Rates of Fast and Catastrophic Visual Field Loss in Three Glaucoma Subtypes.

Significant Glaucomatous Visual Field Progression in the First Two Years: What Does It Mean?

The Risks and Benefits of Myopia Control.

Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2).

Neuroprotective strategies for retinal disease.